Potassium Bromide
Active ingredient
Sold as KALI BROMATUM
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 62
Overview
Plain-language summary, compiled from the cited regulatory records
Potassium Bromide is an active pharmaceutical ingredient [1]. Its drug class is not specified in the provided data [1]. It is indicated for conditions as listed or as directed by a physician [1].
This ingredient is available under various brand names, including KALI BROMATUM [1]. In the past 12 months, there have been 62 adverse event reports associated with this ingredient [2]. The most frequently reported adverse events include off-label use, congenital hiatus hernia, somnolence, prolonged activated partial thromboplastin time, and product dose omission issues [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | October 1, 2021 |
USUnited States· FDA
1 product
Uses
INDICATIONS
Condition listed above or as directed by the physician
How to take
Sources & citations
- [1]FDA DailyMed · 04572087-c0c2-4e… · revised October 1, 2021 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.